2′-Fluoronucleosides

Details 2′-Fluoronucleosides 2′-Fluoronucleosides

2007-12-11

2007-12-11

Riley, Jezia (Department: 1637)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S001000, C536S001110, C536S004100

Reexamination Certificate

active

10796529

ABSTRACT:
A class of 2′-fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae:whereinBase is a purine or pyrimidine base;R1is OH, H, OR3, N3, CN, halogen, including F, or CF3, lower alkyl, amino, loweralkylamino, di(lower)alkylamino, or alkoxy, and base refers to a purine or pyrimidine base;R2is H, phosphate, including monophosphate, diphosphate, triphosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of providing a compound wherein R2is H or phosphate; sulfonate ester including alkyl or arylalkyl sulfonyl including methanesulfonyl, benzyl, wherein the phenyl group is optionally substituted with one or more substituents as described in the definition of aryl given above, a lipid, an amino acid, peptide, or cholesterol; andR3is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group which when administered in vivo, is capable of being cleaved to the parent compound, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4000137 (1976-12-01), Dvonch et al.
patent: 4211773 (1980-07-01), Lopez et al.
patent: 4336381 (1982-06-01), Nagata et al.
patent: 4625020 (1986-11-01), Brundidge et al.
patent: 4666892 (1987-05-01), Fox et al.
patent: 4908440 (1990-03-01), Sterzycki et al.
patent: 5034518 (1991-07-01), Montgomery et al.
patent: 5128458 (1992-07-01), Montgomery et al.
patent: 5210085 (1993-05-01), Liotta et al.
patent: 5246924 (1993-09-01), Fox et al.
patent: 5424416 (1995-06-01), Jones et al.
patent: 5426183 (1995-06-01), Kjell et al.
patent: 5446029 (1995-08-01), Eriksson et al.
patent: 5512671 (1996-04-01), Piantodosi et al.
patent: 5565438 (1996-10-01), Chu et al.
patent: 5567688 (1996-10-01), Chu et al.
patent: 5587362 (1996-12-01), Chu et al.
patent: 5703058 (1997-12-01), Schinazi et al.
patent: 5808040 (1998-09-01), Chu et al.
patent: 5817799 (1998-10-01), Marquez et al.
patent: 5886162 (1999-03-01), Kalman et al.
patent: 5905070 (1999-05-01), Schinazi et al.
patent: 6103707 (2000-08-01), Yamada et al.
patent: 6147058 (2000-11-01), Yoshimura et al.
patent: 6232300 (2001-05-01), Schinazi et al.
patent: 6348587 (2002-02-01), Schinazi et al.
patent: 6407077 (2002-06-01), Gosselin et al.
patent: 6458773 (2002-10-01), Gosselin et al.
patent: 6911424 (2005-06-01), Schinazi et al.
patent: 2002/0198171 (2002-12-01), Schinazi et al.
patent: 0292023 (1988-05-01), None
patent: 0316017 (1989-05-01), None
patent: 0 352 248 (1990-01-01), None
patent: 0382526 (1990-08-01), None
patent: 0409227 (1991-01-01), None
patent: 0463470 (1992-01-01), None
patent: 0357571 (1996-04-01), None
patent: 0839813 (1998-05-01), None
patent: WO88/08001 (1988-10-01), None
patent: WO91/11186 (1991-08-01), None
patent: WO92/08727 (1992-05-01), None
patent: WO92/14743 (1992-09-01), None
patent: WO94/14831 (1994-07-01), None
patent: WO95/20595 (1995-08-01), None
patent: WO96/22778 (1996-08-01), None
patent: WO96/40164 (1996-12-01), None
patent: WO97/28177 (1997-08-01), None
patent: WO97/37993 (1997-10-01), None
patent: WO98/18430 (1998-05-01), None
patent: WO99/43691 (1999-09-01), None
Balakrishna, P.S., et al., “Inhibition of Hepatitis B. Virus by a Novel L-Nucleoside, 2′-Fluoro-5-Menthyl—L- arabinofuranosyl Uracil,”Amtimicrobial Agents and Chemotherapy, 40(2):380-386 (Feb. 1996).
Borthwick, et al., “Synthesis and Enzymatic Resolution of Carbocyclic 2′-Ara-fluoro-Guanosine; A Potent New Anti-Herpetic Agent,”J. Chem Soc., Chem. Commun., (1988).
Bouffard, D.Y., et al., “Kinetic Studies of 2′,2′-Difluorodeoxycytidine (Gemcitabine) with Purified Human Deoxycytidine Kinase and Cytidine Deaminase,”Biochemical Pharmacology, 45(9):1857-1861 (May 5, 1993).
Cheng, et al., “Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/−)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication,”Journal of Biological Chemistry, vol. 267(20):13938-13942 (Jul. 1992).
Chu, et al., “Use of 2′-Fluoro-5-methyl—L-arabinofuranosyluracil as a Novel Antiviral Agent for Hepatitis B. Virus and Epstein-Barr Virus”Antimicrobial Agents and Chemotherapy, 39(4):979-981 (Apr. 1995).
Furman, et al., “The Anti-Hepatitis B. Virus Activities, Cytotoxicities, and Anabolic Profiles of the (−) and (+) Enantiomers of cis-5-Fluoro-1[2-(Hydroxymethyl)-1, 3-oxathiolane-5-yl]-Cytosine”Antimicrobial Agents and Chemotherapy, 36(12):2686-2692 (Dec. 1992).
Jeong, L.S., et al., “Facile Fluorination of Deoxy-4′-thiopyrimidine Nucleosides with ‘Down’ Hydroxyl Groups. Retention of Configuration After Fluoride Opening of the Quaternized N3-MEM Anhydronucleosides,”Tetrahedron Letters, 35(41):7573-7576 (1994).
Jeong, L.S., et al., “Unanticipated Retention of Configuration in the DAST Fluorination of Deoxy-4′-thiopyrimidine Nucleosides with ‘Up’ Hydroxyl Groups,”Tetrahedron Letters, 35(41):7569-7572 (1994).
Machida, H., et al., “Anti-herpesvirus activity profile of 4′-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2′-fluoro-4′-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus.”Antiviral Res., 39(2):129-137 (Aug. 1998).
Marquez, V.E., et al.,Nucleosides&Nucleotides, 14(3-5):555-558 (1995).
Martin, et al., Synthesis and Antiviral Activity of Monofluoro and Difluoro Analogues of Pyrimidine Deoxyribonucleosides against Human Immunodeficiency Virus (HIV-1),J. Med., Chem., 33:2137-2145 (1990).
Montgomery, J.A., et al., “9-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)guanine: A Metabolically Stable Cytotoxic Analogue of 2′-Deoxyguanosine,”J. Med. Chem., 29(11):2389-2392 (Nov. 1986).
Niihata, S., et al., “Synthesis of 2-Fluoro Sugar and Its Condensation Reaction with Silylated Thymine,”Bull. Chem. Soc. Jpn. 68(5):1509-1512 (May 1995).
Okabe, M., et al., “Synthesis of 1-(2,3-Dideoxy-2-fluoro-β-D-threo-pentofuranosyl)cytosine (F-ddC). A Promising Agent for the Treatment of Acquired Immune Deficiency Syndrome,”J. Org. Chem. 56:4392-4397 (Feb. 1991).
Schinazi, et al., “Selective Inhibition of Human Immunodefiency viruses by Racemates and Enantiomers of cis-5-Fluoro-1-2[Hydroxymethyl)-1, 3-Oxathiolane-5-Yl]Cytosine”Antimicrobial Agents and Chemotherapy, 36(11):2423-2431 (Nov. 1992).
Schinazi, et al., Mutations in retroviral genes associated with drug resistance,International Antiviral News(1997).
Siddiqui, M.A., et al., “A New Synthetic Approach to the Clinically Useful, Anti-HIV Active Nucleoside, 9-(2,3-Dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (beta-FddA). Introduction of a 2′-beta-Fluoro Substituent via Inversion of a Readily Obtainable 2′-alpha-Fluoro Isomer,”Tetrahedron Letters, 39(13):1657-1660 (Mar. 26, 1998).
Sterzycki, et al., “Synthesis and Anti-HIV Activity of Several 2′-Fluoro-Containing Pyrimidine Nucleosides,”J. Med. Chem., 33(8):2150-2157 (Aug. 1990).
Su, T.S., et al., “Sythesis and Antiviral Effects of Several 1-(2-Deoxy-2-fluoro-B-D-arabinofuranosyl)-5-alkyluracils. Some Structure-Activity Relationships,”J. Med. Chem., 29:151-154 (1986).
Toyota, A., et al.,Tetrahedron, 51(32):8783-8798 (1995).
Van Aerschot, A., et al., “3′-Fluoro-2′,3′-dideoxy-5-chlorouridine: Most Selective Anti-HIV-1 Agent among a Series of New 2′- and 3′-Fluorinated 2′,3′-Dideoxynucleoside Analogues.”,J. Med. Chem. 32(8):1743-1749 (Aug. 1989).
Wantanabe, et al., “Synthesis and Anti-HIV Activity of 2′-“Up”-Fluoro Analogues of Active Anti-Aids Nucleosides 3′-Azido-3

Affiliated with

Also associated with

Rating

2′-Fluoronucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2′-Fluoronucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2′-Fluoronucleosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3834673